Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 

Letter From The Editor

Editor's Note, DCMS #167:

Most of the time when we see our type 2 patients we look at the excess fat hanging over their belts and wish we could just get them to lose this useless mass of stored calories. However, based on what Dr. Osama Hamdy, MD, PhD, FACE, has found, we...


Letter from the Editor, #707:

Last month many of you took the time to read and print our column from Dr. Sheri Colberg on exercises for older adults....


SGLT2 Inhibitor Special Edition, Issue #9

In our last newsletter of the year on SGLT2 inhibitors we are going to look forward to what is in store for 2014 and beyond. This month, our PharmD candidate, Heather Good, has prepared a special feature on the how this class will expand and how...



Editor's Note, DCMS #166:

The FDA does not often reverse their decision on a medication but that has now happened with Avandia. With clinicians potentially using this TZD again, it's a good time to revisit one of the most common errors from the past. The ISMP has had...


Letter from the Editor #706:

On Thursday night I was presenting a program on insulin to medical professionals and I asked the participants how a patient could go to bed with a normal glucose but wake up with a higher glucose in the morning. I heard words like...


Editor's Note, Type 2 Diabetes Special Edition #2: Food Label Confusion

I have been providing diabetes education for the last 19 years and over that time there have been so many methods for diabetes control and management that it would fill up a thumb drive to just list all of them. Currently the main focus seems to be...


Editor's Note, Insulin Special Edition #4: Patient Self-titrating and Type 2

Typically we as medical professionals usually postpone our starting of insulin in type 2 patients as long as possible. This has become easier over the past few years as we have had four new classes of medications come into the market in the...


Editor's Note, DCMS #165: Evidence-based Practice

Is there a difference between evidence-based medicine and evidence-based practice? Dr. Stanley Schwartz thinks so and this week we are going to share his Homerun Slides on


Letter from the Editor, #705: Avandia and FDA Approvals

This week the FDA reversed its previous decision on Avandia (see this week's Item #1). All the hype and bad press that Dr. Steven Nissen of the Cleveland...


Editor's Note, DCMS #164: Cystic Fibrosis Slides

Over 30,000 people in the U.S. have cystic fibrosis and there are about 1,000 new cases a year. Most of these are diagnosed by the age of two and during their lifetimes they will need a lot of life-saving meds. Forty years ago the average survival...


Letter from the Editor #704: HealthCare.gov

There has been so much press over the failure of the ACA website that everyone wants to blame someone. You would think that a government that could fly a drone by remote control 11,000 miles away could get this correct. The continued pressure to...


Editor's Note SGLT2-I #8: The Realities of UTI Risk

Last month we talked about how prescribers were getting over their fear of using SGLT2 Inhibitors because of the warning about urinary tract infections. Although incidence in the clinical trials was low there had been an apparent exaggeration in...


Editor's Note, DCMS # 163: Psychological Issues in Diabetes

Have you ever had a day when your patients just drive you crazy? They haven't had their labs done, they didn't get their last prescription filled, or they've forgotten their log books. If you string enough of these patients together, you can end up...


Letter from the Editor #703:

This week there was a change in guidelines concerning the use of cholesterol lowering medications. New guidelines from the American College of Cardiology...


Editor's Note, DCMS #162: Cystic Fibrosis and Diabetes

There are a lot of diseases caused by recessive traits that can be devastating to our patients with diabetes and even a few that can lead to diabetes. None of these are as deadly and well known as Cystic Fibrosis. This week our intern Afshaun...


Letter from the Editor, #702

For the last year we have had a generic version of the alpha glucosidase inhibitor, Acarbose. Many of you would never prescribe this medication because of the possible side effects of gas and gastric discomfort. In addition there did not appear to...


Special Edition: Type 2 Diabetes, Issue #1

Recently, a doctor who I used to do diabetes classes for called me. We had stopped the classes because of a lack of funding and he wanted to start them again. Part of his reason was to help his patients but he also knew that he was now being graded...


Special Insulin Edition #3: Insulin Therapy in Older Adults

I have spent the past couple of weeks preparing a CE webinar for the American Association of Nurse Assessment Coordination. This organization represents long-term care professionals who provide quality care for nursing home residents across the...


Editor's Note, DCMS #161

Over the past few years there has been a decrease in the ability of clinicians to diagnose and treat patients. According to a study in The Lancet, this decrease in diagnostic ability can be partly blamed on the increased use of smartphones...


Letter from the Editor #701

Last week I shared some information on saturated fat in my Letter from the Editor from the BMJ. Many of...


Editor's Note, DCMS #160

For the past three weeks we have given you a powerpoint presentation on changes in provider care, especially ACOs and PCHMs. During this time we have been discussing the way that these care models are being built and the goals they are striving...


Letter from the Editor #700:

Week after week it seems like old myths about diabetes, lipidemia and hypertension are falling by the wayside. For years we focused on calories and sugar and never made an effort to limit carbohydrates. In fact it has only been in the past five...


SGLT2 Inhibitors Special Edition Issue 7

It has taken a while but the use of the SGLT-2 Inhibitors appear to be catching on. My pharmacist colleagues have been telling me that more clinicians are writing for Invokana and patients are coming in for refills. It seems that some of the early...


Editor's Note, DCMS #159

This past Saturday I was working with 11 patients in an interactive education class at a progressive doctor's office in Palmetto, Florida. This office takes a very unique approach to diabetes and provides every patient who has an A1c of 5.7 or...


Letter from the Editor #699:

When you look up alpha-1 antitrypsin you find out that it is a protease inhibitor belonging to the serpin superfamily, and a deficiency leads to a condition in which the body does not make enough of a protein that protects the lungs and liver from...


Special Edition on Insulin, Issue #2

While we were preparing this endocrinologist-only special edition I realized that I had an opportunity to speak to the insulin experts. I am often called upon to speak to primary care physicians about early insulin use in type 2 patients and...


Editor's Note, DCMS #158

Did you know that clinicians who work for PCMH's actually get paid more money from state Medicaid and other programs than their colleagues who practice medicine "the old-fashioned way"? Payers are realizing that this care model gives...


Letter from the Editor, #698

This week we have an article on how gastric bypass and other laparoscopic procedures can cause remission in diabetes and improve cardiovascular...


Editor's Note, DCMS #157

Have you ever heard of the three letters, VBP? They stand for Value-based Purchasing and represent the latest tool to get high-quality, patient-centered, efficient, affordable healthcare. Our Homerun Slides this week cover


Letter from the Editor #697

This week we have some interesting news about medications for obesity and their effects on diabetes. Our first article looks at the...


Editor's Note, DCMS #156:

By the time that you read this newsletter we will either be in a funding gridlock or not, but regardless the Affordable Care Act will have started. A lot of attention has been on government programs but private health insurance is also affected by...


Letter from the Editor #696:

Friday I was in Dallas to talk to care and case managers from Blue Cross of Texas. The topic was Hospital Readmissions and the impact on the coordination of care continuum. The focus of the presentation was how to keep patients from returning to...


Editor's Note, DCMS #155:

Last weekend, I spent some time with our president, Andrew Young, in Manhattan Beach. I got in some good quality time on the bike while Andrew was surfing in what I would swear was freezing water. Andrew has very well-controlled diabetes and to do...


Letter from the Editor #695: Three Things Your Patients Can Do First Thing in the Morning

Over the years as an educator I have tried to find every advantage for my patients who have diabetes. For some reason many of my medical colleagues feel that if you tell a patient to do things the right way they will do it. Logic says that this...


Editor's Note - Tools for Initiating Insulin: Special Edition

For those of us who are old enough to remember the first Star Trek, or for the rest of you who only know the original series from Nick at Nite reruns, Captain James Kirk would start the show in his rich deep voice by saying "Space:...


Editor's Note, SGLT2-Inhibitor Special Issue #6

Over the past few months we have brought you the latest information on SGLT2 Inhibitors, examining this new class of drugs from every angle including how they work, prescription insurance coverage, and both clinician and patient experience with...


Editor's Note, DCMS #154: Affordable Care Act Slides Series

As we move closer to the implementation of the Affordable Care Act, there are still many unanswered questions as to how things will work, challenges from all sides of the political spectrum and healthcare industry, and a lot of misinformation...


Letter from the Editor, #694: Why Some Obese Patients Don't Get Diabetes

We have seen numerous studies demonstrating the value of resistance exercise for diabetes patients but often we only think of weights and machines and those methods rule out a lot of our patients. This week, Dr. Sheri Colberg brings us


Editor's Note, DCMS #153: How Red Food Dye in a Saline Solution Can Save Lives

Years ago, when a patient was referred to the pharmacy for instructions on how to start insulin, we would add red food coloring to the saline making it easier to see the exact amount of liquid in the test syringe. Over time, I have thought about...


Letter from the Editor #693:

Over the past month, I've done 20 hours of CE including a full day becoming certified at immunizations. In our area, every pharmacy, doctor's office and walk-in clinic offers flu shots, and as we move into the fall, the volume of flu shots...



Navigate through our listing of Letter From The Editor articles here.
First Previous Next Last

645 Total articles for Letter From The Editor


Browse our other news categories below.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Looking for a particular Newsletter Issue? Click Here


Cast Your Vote
Have you recommended the use of an SGLT-2 inhibitor to any of your type 1 patients?

CME/CE of the Week
Lynn Grieger, CDE, RD
ABPM, FACC, FCCWS

Category: Nutrition
Credits: .5


Advertisement